Clinical Trials Browser

Advanced or Metastatic Solid Tumors × pembrolizumab × 30 days × Clear all

NCT06234397 2026-03-11

Dose Escalation and Expansion Study of BH3120 Alone or With Pembrolizuamb in Advanced or Metastatic Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Advanced or Metastatic Solid Tumors